World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
49
Citations
14502
World Ranking
4517
National Ranking
309

Dirk Jäger publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Dirk Jäger sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 201 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Dirk Jäger D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Dirk Jäger sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 49 D-Index — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Dirk Jäger is affiliated with Heidelberg University in Germany and has an extensive publication record primarily focused on medicine and biochemistry, genetics, and molecular biology. Their research spans various subfields including oncology, molecular biology, pulmonary and respiratory medicine, cancer research, and immunology.

The scientist's recent publications demonstrate a focus on cancer and immunotherapy. Notable papers include:

  • Pan-cancer image-based detection of clinically actionable genetic alterations, 2020, Nature Cancer
  • Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction, 2020, Cell
  • Caring for patients with cancer in the COVID-19 era, 2020, Nature Medicine
  • Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas, 2020, Journal of Nuclear Medicine
  • Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC), 2020, European Journal of Heart Failure

Frequent co-authors in their research include:

  • Christoph Springfeld
  • Stefan Fröhling
  • Inka Zörnig
  • Albrecht Stenzinger
  • Stefanie Zschäbitz

Frequent publication venues reflect the scientist's engagement in oncology and molecular biology focused journals, including:

  • Cancers
  • Frontiers in Immunology
  • Frontiers in Oncology
  • Annals of Oncology
  • Nature Cancer

Their work covers a range of main research topics:

  • Cancer Immunotherapy and Biomarkers
  • Pancreatic and Hepatic Oncology Research
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Immunotherapy and Immune Responses
  • Renal cell carcinoma treatment
  • Virus-based gene therapy research

The breadth of Dirk Jäger's research encompasses applied and translational aspects of cancer biology, immunotherapeutic strategies, and diagnostic advancements. Their collaborations and publication record indicate active participation in multidisciplinary cancer research with a significant clinical perspective.

Best Publications

  • Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

    Scott J. Antonia;José A. López-Martin;Johanna Bendell;Patrick A. Ott

  • Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer.

    Jakob Nikolas Kather;Alexander T. Pearson;Niels Halama;Dirk Jäger

  • Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

    Felix Klug;Hridayesh Prakash;Hridayesh Prakash;Hridayesh Prakash;Peter E. Huber;Tobias Seibel

  • Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

    Elke Jäger;Yao Tseng Chen;Jan W. Drijfhout;Julia Karbach

  • Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164

    Dung T Le;Tae Won Kim;Eric Van Cutsem;Ravit Geva

  • Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

    Elke Jäger;Sacha Gnjatic;Yasuhiro Nagata;Elisabeth Stockert

  • Pan-cancer image-based detection of clinically actionable genetic alterations

    Jakob Nikolas Kather;Jakob Nikolas Kather;Lara R. Heij;Lara R. Heij;Heike I. Grabsch;Heike I. Grabsch;Chiara Loeffler

  • The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes

    Davide F Robbiani;Rick A Finch;Dirk Jäger;William A Muller

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

    E Jäger;Y Nagata;S Gnjatic;H Wada

  • Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

    Daniel K. Wells;Marit M. van Buuren;Kristen K. Dang;Vanessa M. Hubbard-Lucey

  • Immunoselection in vivo : independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

    Elke Jäger;Mark Ringhoffer;Michael Altmannsberger;Michael Arand

  • Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

    Elke Jäger;Mark Ringhoffer;Hans Peter Dienes;Michael Arand

  • Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer.

    R.-D. Hofheinz;S.-E. al-Batran;F. Hartmann;G. Hartung

  • Caring for patients with cancer in the COVID-19 era.

    Joris van de Haar;Louisa R. Hoes;Charlotte E. Coles;Kenneth Seamon

  • Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma

    Elke Jäger;Dirk Jäger;Julia Karbach;Yao-Tseng Chen;Yao-Tseng Chen

  • Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

    Sylvie Rusakiewicz;Michaela Semeraro;Matthieu Sarabi;Mélanie Desbois

  • CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy

    Christine E Engeland;Christine E Engeland;Christian Grossardt;Rūta Veinalde;Sascha Bossow

  • Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.

    Ali O. Güre;Elisabeth Stockert;Matthew J. Scanlan;Roger S. Keresztes

  • Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events.

    Elke Jäger;Elisabeth Stockert;Zacharias Zidianakis;Yao-Tseng Chen;Yao-Tseng Chen

  • Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

    Elke Jäger;Julia Karbach;Sacha Gnjatic;Antje Neumann

  • Topography of cancer-associated immune cells in human solid tumors

    Jakob Nikolas Kather;Meggy Suarez-Carmona;Meggy Suarez-Carmona;Pornpimol Charoentong;Pornpimol Charoentong;Cleo-Aron Weis

  • Seromic profiling of ovarian and pancreatic cancer

    Sacha Gnjatic;Erika Ritter;Markus W. Büchler;Nathalia A. Giese

  • Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study

    André Hennigs;Fabian Riedel;Adam Gondos;Peter Sinn

  • Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.

    Unknown

  • Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8

    Unknown

  • Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene

    Dirk Jäger;Elisabeth Stockert;Matthew J. Scanlan;Ali O. Güre

  • Consensus nomenclature for CD8+ T cell phenotypes in cancer

    Lionel Apetoh;Mark J. Smyth;Charles G. Drake;Jean Pierre Abastado

Frequent Co-Authors

Alexander Knuth
Alexander Knuth University of Zurich
Elke Jäger
Elke Jäger Goethe University Frankfurt
Yao-Tseng Chen
Yao-Tseng Chen Cornell University
Markus W. Büchler
Markus W. Büchler Champalimaud Foundation
Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Hanno Glimm
Hanno Glimm TU Dresden
Peter Schirmacher
Peter Schirmacher University Hospital Heidelberg
Benedikt Brors
Benedikt Brors German Cancer Research Center
Uwe Haberkorn
Uwe Haberkorn Heidelberg University
Elisabeth Stockert
Elisabeth Stockert Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Microbiology in the USA, exploring related degrees can broaden career opportunities, especially in health and information management sectors. Those interested in the administrative and coding side of healthcare should consider programs focused on medical billing and coding. Enrolling in a fast track medical billing and coding certificate online can provide a quick pathway to entry-level roles with promising growth.

Health Information Management (HIM) is another complementary field. Graduates equipped with a health information management bachelor degree salary report competitive income, reflecting growing demand for professionals who handle healthcare data and patient records efficiently. It’s vital to choose reputable programs, and candidates should seek out cahiim accredited health information management programs online to ensure quality education and industry recognition.

Additionally, becoming a Certified Professional Coder can enhance career prospects. Those curious about compensation and advancement can review insights on cpc salary to evaluate potential benefits of this specialization in the healthcare field. Combining microbiology knowledge with health information expertise equips graduates to thrive in multidisciplinary environments.

Best Scientists Citing Dirk Jäger

Trending Scientists

Recently Published Articles